9999999997-13-011256.txt : 20130701 9999999997-13-011256.hdr.sgml : 20130701 20130701131201 ACCESSION NUMBER: 9999999997-13-011256 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130701 DATE AS OF CHANGE: 20130701 20130701 20130701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HELIX BIOMEDIX INC CENTRAL INDEX KEY: 0000831749 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 912099117 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 033-20897 FILM NUMBER: 13943698 BUSINESS ADDRESS: STREET 1: 22121 17TH AVE SE STREET 2: SUITE 112 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 425 402 8400 MAIL ADDRESS: STREET 1: 22121 17TH AVE SE STREET 2: SUITE 112 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: CARTEL ACQUISITIONS INC DATE OF NAME CHANGE: 19890718 FORMER COMPANY: FORMER CONFORMED NAME: CARIBBEAN ACQUISTIONS INC DATE OF NAME CHANGE: 19880725 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T M:"`V,B]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``(.&094P`C$+`P<#%LP(#`@-C$R(#7!E+T]B:E-T;3X^RM46(*]USKNZ1=%@(%)@`$0.+ M@'DFQ.`)#IR"B"AP!HQ2`5=7Y/:H[Q(MM3+KNX1A%87[\9C,JE*;7)IR+#8Y ML_2QTL'+NMHD2J_(\F9&4G74Z_'8T+\MX:?,&V46RR/+G#VE6J`86ZA?<5X4L/UIL(0M%+&(`FU\FHVF5 M;^>IQ1-=*[W9DT55%S*WJ01XX#C*&C?QF^J44NQE9[>XJ+B%WJ MPTQ/_?J]!@PO#4C%VPSX3^_Y+W@OXN^SWEM=Q^G0=?P5KCL/]!G.__-=_R^[ MGQZZKO,-.L[]-NYLGRBVS*B-YYHS[T^/N9[6:?0RXIF=JK[OT,E#U5U_WL.L MT]NU.<]X\;<``P!A*H>6#0IE;F1S=')E86T-96YD;V)J#3$T(#`@;V)J#3P\ M+T9I;'1E4M"_N%>ZQ&SA&-`HA? M.QYL.R[U/'\`\;IC%V^=OYSG^2R>$#>@`V<,2^)R&CHQH;XSC,W;B7T)Y._X M6\?MTS#DX/K4YQ"/M4ZO;W6JA=*YG(R>%[-X1O!V@`I@.!\#&NG1OO/GZ&$X MO[<;&#T]/LZ6R]G3W*B/*&-GY4JEKW2[=O76<;XUV1'\+C#/[P&)_^TPRH,+ MASQUW]-7];'K,^H%[QQN0?`L"$^+\60!]\1%U)S%12H/79CE:TI\#ZT8 M(^]TW-CH(][G8V!I">1G8/G99B+0HO_\ M\G?*VH43QG3\NXXH.D44F8B`N"SDWD5DA#O7P44.5`WA^%R]D@B9)^M:I)#D MD)``M_M])M=F6MP03$F=Y7LFP!H%T;>> M`^LB)WUX'S//HOP#:E;"MPEE5%8"H2Y MPNAUC!6LCG!%?&V`>93W?H$[XT:K)I".7;%(@0/H?(1Q)374.WTB*X7H)<*7 MV/YHDDS:9(G*8F?,7D%W,NW9E">5RO7&9CC#S:L"#A-:KM6^*!&\/,GUQC0' M3@?^F46F*;L77=DF/L*6;)QK-+]5DJ:E$&EASA1)9^^OVJ0;$]>]U&][J>G/ MPW7=!0[/=$E'%#AG+\[JA;PXP0OI:EMC^5.VQ:#9WZ?LTN\;*$9%N2]*X\=4 MQRQ@A_BDHA:E`47FF/6\J!7)K*M&ZQ7(X:FN0J-YWZRP[#$[W,&ADLJ*J(&W M1L[CBZ(26!H48&ANK(LRQ6(G:A9F!!5SY]C%RE%G!X(O;>&89(2TW[\(:G`R M/3@E`]O'`#F#F#HZC-!B;0Y*9<)WBE<-6GL9_V59\:::CE"%I:6Q@-]DEK61 M&],?5&:@DZ2@6@DLDDSH@D'8E!6+AVE):M)X'TX10()HF5JB[XY`;QW8BU(6 M*51[L98;*=*OYV;QZ=RR5:V9Q&@8#"Q(`&W[`*++6XTI'"HL"+B#ULNBV>[L MT;)T5_69=R0W?(BP[F(ZR:I+OC5RWM?8K_[<*]3`D_`:!_DTS^EZQ$W8+_2-M%4^YWQZMIV#]E M-;A4L13K4M1)>40*]YW/&OY'BTG<^5^``0`*BKLO#0IE;F1S=')E86T-96YD M;V)J#3$@,"!O8FH-/#PO1FEL=&5R+T9L871E1&5C;V1E+T9I7!E+T]B:E-T;3X^R`(L'Z+G9V``$&`(V%"#<-"F5N9'-T7!E+UA-3"]4>7!E+TUE M=&%D871A/CYS=')E86T-"CP_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5- M,$UP0V5H:4AZDY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB M861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,BUC M,#`Q(#8S+C$S.30S.2P@,C`Q,"\P.2\R-RTQ,SHS-SHR-B`@("`@("`@(CX* M("`@/')D9CI21$8@>&UL;G,Z&UL;G,Z<&1F/2)H='1P.B\O M;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D9CI0&UL M;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT"UD969A=6QT(CY-:6-R M;W-O9G0@5V]R9"`M(#(Y.#0P+F]R9&5R/"]R9&8Z;&D^"B`@("`@("`@("`@ M(#PO4P\+W)D9CIL:3X*("`@("`@("`@("`@/"]R9&8Z M4V5Q/@H@("`@("`@("`\+V1C.F-R96%T;W(^"B`@("`@(#PO&UP34TZ26YS=&%N8V5)1#YU=6ED.C!C M.#9C9CAC+3%B-&(M-&$X8BUA,#8X+3(V,3-A,S)D,S=F-3PO>&UP34TZ26YS M=&%N8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#POJ' M5!:DZ@Q`B:<7 M@"P&!D8@P?0?2#`R``08`'>$!1L-"F5N9'-T